推薦: 檢驗(yàn)設(shè)備 | 影像設(shè)備 | 手術(shù)/急救設(shè)備 | 超聲設(shè)備 | 電子儀器 | 激光儀器 | 治療康復(fù)設(shè)備 | 病房護(hù)理設(shè)備 | 醫(yī)用光學(xué) | 冷療/冷藏設(shè)備 | 實(shí)驗(yàn)室設(shè)備 | 幻燈課件 | 臨床用藥 |
![]() |
首頁(yè) > 美迪醫(yī)訊 > Ventria公司推出植物來源的細(xì)胞培養(yǎng)基 |
Ventria公司推出植物來源的細(xì)胞培養(yǎng)基 【?2005-08-02 發(fā)布?】 美迪醫(yī)訊
一種用于細(xì)胞培養(yǎng)的新型植物來源的重組生長(zhǎng)因子,將會(huì)提升產(chǎn)量和安全性。 該產(chǎn)品被稱為L(zhǎng)acromin,是一種來源于植物的重組人乳鐵蛋白,這種因子要優(yōu)于通常使用的動(dòng)物來源生長(zhǎng)因子轉(zhuǎn)鐵蛋白。Lacromin是Ventria生物科學(xué)公司的產(chǎn)品。 Lacromin是一種強(qiáng)大的生長(zhǎng)因子,能夠促進(jìn)許多細(xì)胞株的生長(zhǎng),包括中國(guó)地鼠卵巢細(xì)胞和小鼠雜交瘤細(xì)胞。它還能夠提高細(xì)胞密度,與轉(zhuǎn)鐵蛋白相比,能夠較少細(xì)胞增殖一倍的時(shí)間。因?yàn)長(zhǎng)acromin來自植物,所以沒有任何病毒和或者朊病毒污染的危險(xiǎn)。在雜交瘤細(xì)胞株中,與使用轉(zhuǎn)鐵蛋白相比,Lacromin能夠?qū)gG產(chǎn)量增加50%,與胎牛血清相比,增加6%。 “我們對(duì)Lacromin的這些結(jié)果感到十分鼓舞。”Ventria生物科學(xué)公司研究與開發(fā)部副總裁Ning Huang如此評(píng)論。Huang先生2005年7月在堪薩斯市舉行的“哺乳動(dòng)物細(xì)胞培養(yǎng)產(chǎn)品原材料和一次性處理系統(tǒng)大會(huì)”上介紹了Lacromin。“在今天的會(huì)議上,我報(bào)道的結(jié)果顯示:與動(dòng)物來源的轉(zhuǎn)鐵蛋白相比較,Lacromin能夠顯著增加抗體的產(chǎn)量。” 該公司將會(huì)把Lacromin推介給那些尋求無(wú)血清和無(wú)動(dòng)物成分的細(xì)胞培養(yǎng)基的公司。 Called Lacromin, the growth factor is a recombinant human lactoferrin derived from plants, which outperforms transferrin, a common animal-derived growth factor. Lacromin is the product of Ventria Bioscience (Sacramento, CA, USA). Lacromin is a strong growth factor that has promoted cell growth in many cell lines, including Chinese hamster ovary (CHO) cells and mouse hybridoma cells. The growth factor also promotes higher cell density and reduces cell doubling time when compared to transferrin. Since Lacromin is derived from plants, it is free of any viral or prion containment risks. In hybriderma cells, Lacromin increased IgG productivity by 50% compared to transferrin and by 6% compared to fetal bovine serum (FBS). “We are very encouraged by the positive results we have generated on Lacromin,” said Ning Huang, vice president of research and development, Ventria Bioscience. Mr. Huang introduced Lacromin at the Raw Materials and Disposable Process Systems for Mammalian Cell Culture Products Conference in Kansas City (MO, USA) in July 2005. “At the conference today, I presented results showing Lacromin significantly increased the productivity of antibody production when compared with animal-derived transferrin.” The company will market Lacromin to companies seeking a serum-free and animal component-free cell culture media source. 本文關(guān)鍵字:
Ventria公司,植物,細(xì)胞培養(yǎng)基
《美迪醫(yī)訊》歡迎您參與新聞投稿,業(yè)務(wù)咨詢: 美迪醫(yī)療網(wǎng)業(yè)務(wù)咨詢更多關(guān)于 Ventria公司,植物,細(xì)胞培養(yǎng)基 的新聞《上海醫(yī)療器械批發(fā)》產(chǎn)品推薦
|